Search

everythinglearnresearchcommunity

for

Search:↓

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

MC-1R in skin cells may influence inflammation and collagen production.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Lower SMAD2/3 activation predicts more severe skin cancer.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

Tofacitinib may effectively treat folliculitis decalvans.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Blocking mTORC1 activity with rapamycin could help increase hair pigmentation and growth, potentially reversing gray hair.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

A new method improves betulin delivery and shows promise in cancer treatment.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

M30 is a promising treatment for preventing hair loss during chemotherapy.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Different types of skin gland tumors have unique genetic traits, which can guide personalized treatments.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Curcumin may improve cancer radiotherapy by making cancer cells more sensitive to radiation and protecting normal cells.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.